Main content

Ebola: taming the virus.

Ebola's economic impact and what the world needs to do to control the disease. Should pharmaceutical companies be doing more to fast-track a vaccine? Or is it down to governments?

The World Health Organisation says that nearly 900 people have now died in the latest outbreak of the ebola virus in Guinea, Liberia and Sierra Leone. But the economic impact of the disease is spreading even faster than the virus itself. Farms are being abandoned, mine operations suspended, and borders sealed, with serious consequences for the populations of some of the world's poorest nations. We get a report from the region, and we hear about those economic consequences from Manji Cheto, a UK-based specialist on the region with Teneo Intelligence, a Risk Consultancy. We also examine the clinical responses to the crisis with two specialists: Dr Kartik Chandran, an associate professor of microbiology & immunology at the Albert Einstein College of Medicine in New York, and Ian Jones, Professor of Immunology at the UK's University of Reading. Should the leading pharmaceutical companies be doing more to fast-track a vaccine? Or is it simply the job of aid agencies and governments to make sure the disease does not spread?

Available now

18 minutes

Last on

Tue 5 Aug 2014 07:32GMT

Broadcast

  • Tue 5 Aug 2014 07:32GMT

Podcast